Recombinant adeno-associated viral vector encoding human VEGF165 induces neomicrovessel formation in the adult mouse brain

Recombinant adeno-associated viral vector encoding human VEGF165 induces neomicrovessel formation in the adult mouse brain
复制标题

DOI:
10.2741/2042
复制
发表时间:
2006-09-01
影响因子:
3.1
通讯作者:
Yang, Guo-Yuan
Yang, Guo-Yuan
中科院分区:
生物学4区
文献类型:
--
作者:
Shen, Fanxia;Su, Hua;Yang, Guo-Yuan

文献摘要

被引文献

相似文献

治疗性基因的传递代表了一种迷人的可能性,可以加速组织中难以治疗的损伤修复过程,如脑缺血。目前的研究表明,基因转移诱导的局部脑血管生成可能提供一个重要的治疗策略。在本研究中,我们报道了用腺相关病毒(AAV)载体表达血管内皮生长因子(VEGF 165)的165个氨基酸亚型诱导血管生成的功效。我们发现AAV血清型1比AAV血清型2具有更高的脑组织转导效率。定量血管计数显示,与对照组相比,AAV-VEGF转导的小鼠中的微血管从1周至12周显著增加(AAV-VEGF:316 +/-58 vs. AAV-lacZ:180 +/-34和盐水:152 +/-35血管/mm(2),在6周时,p < 0.05)。增殖细胞核抗原(PCNA)染色证实这些微血管增殖活跃。荧光双标染色结果显示,AAV-VEGF基因转染后,神经元、星形胶质细胞和内皮细胞均可表达VEGF。AAV载体没有引起可检测的炎症反应、细胞损失或神经元损伤。我们的数据强调了血管生成在脑组织中的重要性,并表明VEGF基因转移可能是治疗脑缺血性疾病的一种有价值的方法。
Delivery of therapeutic genes represents a fascinating possibility to accelerate injury-repairing process in tissues that are otherwise difficult to treat, such as cerebral ischemia. Current studies indicate that gene transfer-induced focal angiogenesis in the brain may provide an important therapeutic strategy. In the present study, we reported the efficacy of induction of angiogenesis with an adeno-associated virus (AAV) vector expressing the 165 amino acid isoform of vascular endothelial growth factor (VEGF165). We found AAV serotype 1 has more efficiency in transduction of the brain tissue than AAV serotype 2. Quantitative vessel counting showed that microvessels in AAV-VEGF transduced mice significantly increased from 1 week up to 12 weeks compared to the control groups (AAV-VEGF: 316 +/- 58 vs. AAV-lacZ: 180 +/- 34 and saline: 152 +/- 35 vessels/mm(2), at 6 weeks, p < 0.05). Proliferating cell nuclear antigen (PCNA) staining confirmed these microvessels were actively proliferating. Double-labeled fluorescence staining demonstrated that neurons, astrocytes, and endothelial cells could express VEGF following AAV-VEGF gene transfer. AAV vectors did not elicit a detectable inflammatory response, cell loss or neuronal damage. Our data underline the importance of angiogenesis in the brain tissue and indicate that VEGF gene transfer might present a valuable approach to treat brain ischemic disorders.